Taylor Morrison Home
TMHC
Meritage Homes
MTH
D.R. Horton
DHI
Lennar Corp
LEN
Toll Brothers
TOL
US Stock MarketDetailed Quotes
HIMS Hims & Hers Health
- 39.860
- -11.450-22.32%
Close Feb 25 16:00 ET
- 39.150
- -0.710-1.78%
Post 20:01 ET
8.86BMarket Cap75.21P/E (TTM)
43.220High36.020Low82.83MVolume39.880Open51.310Pre Close3.24BTurnover42.98%Turnover Ratio75.21P/E (Static)222.17MShares72.98052wk High18.57P/B7.68BFloat Cap11.20052wk Low--Dividend TTM192.72MShs Float72.980Historical High--Div YieldTTM14.03%Amplitude2.720Historical Low39.111Avg Price1Lot Size
About Hims & Hers Health Company
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Company Profile
SymbolHIMS
Company NameHims & Hers Health
Listing DateSep 13, 2019
Founded2017
CEOMr. Andrew Dudum
MarketNYSE
Employees1637
Fiscal Year Ends12-31
Address2269 Chestnut Street,Suite 523
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94123
Phone1-415-851-0195
Websitehttp://www.forhims.com
Company Executives
- Name
- Position
- Salary
- Andrew Dudum
- Chief Executive Officer and Chairman of the Board
- 14.40M
- Mike Chi
- Chief Commercial Officer
- 6.71M
- Dr. Patrick Carroll, M.D.
- Director and Chief Medical Officer
- 198.26K
- Oluyemi Okupe
- Chief Financial Officer
- 7.43M
- Soleil Boughton
- Chief Legal Officer and Corporate Secretary
- 5.21M
- Melissa Baird
- Chief Operating Officer
- 6.77M
- Irene Becklund
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Anja L. Manuel
- Independent Director
- --
- Christopher D. Payne
- Independent Director
- --
- Dr. Delos Cosgrove, M.D.
- Independent Director
- 194.26K
- Andrea G. Perez Garcia
- Independent Director
- 205.51K
- Kare Schultz
- Independent Director
- --
- Deborah M. Autor
- Independent Director
- --
- Christiane Pendarvis
- Independent Director
- 715.39K
- David Bolling Wells
- Lead Independent Director
- 227.41K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.